Get startedLog in
    Picture of GlaxoSmithKline Pharmaceuticals logo

    GLAXO — GlaxoSmithKline Pharmaceuticals News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Samsung Biologics Signs 439.4 Billion Won Contract

    Picture of GlaxoSmithKline Pharmaceuticals logoGlaxoSmithKline Pharmaceuticals
    05/08/2020 08:08
    Aug 5 (Reuters) - Samsung Biologics Co Ltd  207940.KS :
    * SAMSUNG BIOLOGICS: SIGNS 439.4 BILLION WON ($369.7
million)
CONTRACT
    * SAMSUNG BIOLOGICS: TO CONTRACT MANUFACTURE DRUGS FOR
GALXOSMITHKLINE TRADING SERVICES UNTIL END OF 2022

Source text for Eikon: [https://bit.ly/3gvjMzz]
Further company coverage:  207940.KS 

($1 = 1,188.6300 won)

 ((hyunjoo.jin@thomsonreuters.com;))

    Recent news on GlaxoSmithKline Pharmaceuticals

    See all news